Sanders takes aim at US drug prices of Novo’s Ozempic and Wegovy
A Senate Committee is investigating the “outrageously high” US price tags of the blockbuster diabetes and obesity drugs.
Markets
Readmission on the Horizon: How EU funding can boost British biotech
Price point is a key factor for wider market adoption of Amgen’s Amjevita in the US
Pharma sector reels as UK Government doubles VPAS payback rate on NHS drugs
H2 2022 to see the decline of Covid-19 vaccines as forecasts decrease
Money moves: How the biotech market is weathering inflationary storms
Current and future players in the lupus market
Novo Nordisk submitting once-weekly insulin to FDA following Phase III success
